FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895881102> ?p ?o ?g. }

• W2895881102 endingPage "2791" @default.
• W2895881102 startingPage "2791" @default.
• W2895881102 abstract "：The purpose of this study was to identify the anti-inflammatory activity and mechanism of isomaltodextrin (IMD) in a C57BL/6NCrl mouse model with lipopolysaccharide (LPS)-induced systemic low-grade chronic inflammation and the effect on inflammation-induced potential risk of metabolic disorders. Pre-treatment of IMD decreased the production of pro-inflammatory mediators, TNF-α and MCP-1, and stimulated the production of the anti-inflammatory mediator, adiponectin by increasing the protein expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) in the white adipose tissues. IMD administration reduced plasma concentrations of endotoxin, decreased macrophage infiltration into adipocytes, and increased expression of mucin 2, mucin 4, and the tight junction protein claudin 4. These results suggest that IMD administration exerted an anti-inflammatory effect on mice with LPS-induced inflammation, potentially by decreasing circulating endotoxin, suppressing pro-inflammatory mediators and macrophage infiltration, or by improving mucus or tight junction integrity. IMD exerted protein expression of insulin receptor subset-1 (IRS-1). IMD alleviated the disturbance of gut microflora in LPS-treated mice, as the number of B. bifidum, L. casei, and B. fragilis increased, and E. coli and C. difficile decreased, when compared to LPS-treated mice. The analysis of short chain fatty acids (SCFAs) further supported that the concentrations of acetic and butyric acids were positively correlated with IMD, as well as the number of beneficial bacteria. This study provides evidence that IMD possesses anti-inflammatory properties and exerts beneficial functions to prevent systemic low-grade chronic inflammation and reduces the risk of developing insulin resistance and associated metabolic diseases." @default.
• W2895881102 created "2018-10-26" @default.
• W2895881102 creator A5016115301 @default.
• W2895881102 creator A5018264265 @default.
• W2895881102 creator A5023341172 @default.
• W2895881102 creator A5026468444 @default.
• W2895881102 creator A5035096594 @default.
• W2895881102 creator A5052101352 @default.
• W2895881102 creator A5054180905 @default.
• W2895881102 creator A5060844834 @default.
• W2895881102 creator A5089493057 @default.
• W2895881102 date "2019-11-15" @default.
• W2895881102 modified "2023-09-27" @default.
• W2895881102 title "Anti-Inflammatory Activity of Isomaltodextrin in a C57BL/6NCrl Mouse Model with Lipopolysaccharide-Induced Low-Grade Chronic Inflammation" @default.
• W2895881102 cites W137530444 @default.
• W2895881102 cites W1480634774 @default.
• W2895881102 cites W1500165569 @default.
• W2895881102 cites W1694069654 @default.
• W2895881102 cites W1935912749 @default.
• W2895881102 cites W1968070258 @default.
• W2895881102 cites W1987782779 @default.
• W2895881102 cites W1988109900 @default.
• W2895881102 cites W1988725412 @default.
• W2895881102 cites W1988870963 @default.
• W2895881102 cites W1992152055 @default.
• W2895881102 cites W2001787555 @default.
• W2895881102 cites W2013481165 @default.
• W2895881102 cites W2014729719 @default.
• W2895881102 cites W2017298826 @default.
• W2895881102 cites W2019419945 @default.
• W2895881102 cites W2023007981 @default.
• W2895881102 cites W2031558979 @default.
• W2895881102 cites W2035745018 @default.
• W2895881102 cites W2039011877 @default.
• W2895881102 cites W2053200285 @default.
• W2895881102 cites W2053668231 @default.
• W2895881102 cites W2058460917 @default.
• W2895881102 cites W2067817632 @default.
• W2895881102 cites W2086082646 @default.
• W2895881102 cites W2087011218 @default.
• W2895881102 cites W2092406284 @default.
• W2895881102 cites W2096876054 @default.
• W2895881102 cites W2101976554 @default.
• W2895881102 cites W2107277218 @default.
• W2895881102 cites W2115033553 @default.
• W2895881102 cites W2116946576 @default.
• W2895881102 cites W2126320556 @default.
• W2895881102 cites W2127906539 @default.
• W2895881102 cites W2129974818 @default.
• W2895881102 cites W2130078845 @default.
• W2895881102 cites W2131140036 @default.
• W2895881102 cites W2131336057 @default.
• W2895881102 cites W2133808995 @default.
• W2895881102 cites W2138411980 @default.
• W2895881102 cites W2140380746 @default.
• W2895881102 cites W2147273529 @default.
• W2895881102 cites W2155379427 @default.
• W2895881102 cites W2165202791 @default.
• W2895881102 cites W2167497377 @default.
• W2895881102 cites W2169330513 @default.
• W2895881102 cites W2181891910 @default.
• W2895881102 cites W2192080449 @default.
• W2895881102 cites W2196329954 @default.
• W2895881102 cites W2254642444 @default.
• W2895881102 cites W2281390906 @default.
• W2895881102 cites W2414196716 @default.
• W2895881102 cites W2519479884 @default.
• W2895881102 cites W2573885789 @default.
• W2895881102 cites W2619692549 @default.
• W2895881102 cites W2627092521 @default.
• W2895881102 cites W2735527928 @default.
• W2895881102 cites W2801078802 @default.
• W2895881102 doi "https://doi.org/10.3390/nu11112791" @default.
• W2895881102 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6893451" @default.
• W2895881102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31731774" @default.
• W2895881102 hasPublicationYear "2019" @default.
• W2895881102 type Work @default.
• W2895881102 sameAs 2895881102 @default.
• W2895881102 citedByCount "12" @default.
• W2895881102 countsByYear W28958811022020 @default.
• W2895881102 countsByYear W28958811022021 @default.
• W2895881102 countsByYear W28958811022022 @default.
• W2895881102 countsByYear W28958811022023 @default.
• W2895881102 crossrefType "journal-article" @default.
• W2895881102 hasAuthorship W2895881102A5016115301 @default.
• W2895881102 hasAuthorship W2895881102A5018264265 @default.
• W2895881102 hasAuthorship W2895881102A5023341172 @default.
• W2895881102 hasAuthorship W2895881102A5026468444 @default.
• W2895881102 hasAuthorship W2895881102A5035096594 @default.
• W2895881102 hasAuthorship W2895881102A5052101352 @default.
• W2895881102 hasAuthorship W2895881102A5054180905 @default.
• W2895881102 hasAuthorship W2895881102A5060844834 @default.
• W2895881102 hasAuthorship W2895881102A5089493057 @default.
• W2895881102 hasBestOaLocation W28958811021 @default.
• W2895881102 hasConcept C126322002 @default.
• W2895881102 hasConcept C134018914 @default.
• W2895881102 hasConcept C17991360 @default.
• W2895881102 hasConcept C185592680 @default.

• next